TG Therapeutics | Ativos

Assets Alterar Data
AbbVie USD 148.87B 12.65B 2024-03
Amgen USD 92.98B 4.17B 2024-03
Ardelyx USD 342.38M 53M 2024-03
Arrowhead Research USD 955.15M 328.86M 2024-03
Bayer EUR 119.88B 3.62B 2024-03
Biogen USD 26.57B 277.2M 2024-03
Corcept Therapeutics USD 655.94M 34.42M 2024-03
Dynavax Technologies USD 986.56M 10.53M 2024-03
Gilead Sciences USD 56.29B 5.83B 2024-03
J&J USD 171.97B 5.9B 2024-03
Novartis USD 94.33B 5.61B 2024-03
PTC Therapeutics USD 1.79B 106.07M 2024-03
Regeneron Pharmaceuticals USD 34.37B 1.29B 2024-03
Roche Holding CHF 90.47B 6.1B 2023-12
TG Therapeutics USD 373.32M 43.74M 2024-03
Vertex Pharmaceuticals USD 23.92B 2.19B 2024-03



TG Therapeutics Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jun 2024.